Background illustration for clinical trials search

Paid Clinical Trials Texas

Discover 5,035 paid clinical trials in Texas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder

for
RUNX1 Familial Platelet Disorder
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT06414889

Phase 1, Recruiting

Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

for
Neurotrophic Keratopathy
Location: Danbury CT, The Bronx NY, Palisades Park NJ, Norfolk VA,
Sponsor: ReGenTree, LLC

Sex: All

Age: 18+

Code: NCT05555589

Phase 3, Recruiting

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

for
Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID
Location: Ney York NY, New Brunswick NJ, Philadelphia PA,
Sponsor: Philogen S.p.A.

Sex: All

Age: 18+

Code: NCT03567889

Phase 3, Recruiting

Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma

for
Penile Carcinoma
Location: Tampa FL, Houston TX
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: Male

Age: 18+

Code: NCT05526989

Phase 2, Recruiting

A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies

for
Solid Malignancies
Location: Fairfax VA, Dallas TX, San Antonio TX
Sponsor: Carrick Therapeutics Limited

Sex: All

Age: 18+

Code: NCT06600789

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

for
Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations,
Location: Boston MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05967689

Phase 2, Recruiting

Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardiovascular Health

for
Cholesterol, Hyperlipidemia, Hypercholesteremia
Location: San Antonio TX
Sponsor: Integrative Health Technologies, Inc.

Sex: All

Age: 18+

Code: NCT01890889

Recruiting

A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves

for
Post Operative Pain
Location: Manchester NH, Annapolis MD, Orlando FL,
Sponsor: AtriCure, Inc.

Sex: All

Age: 12+

Code: NCT05110989

Recruiting

Pelvic Angioembolization: A Prospective Multi-Institutional Study (Data From All Campuses Will be Used)

for
Pelvic Hemorrhage
Location: Dallas TX
Sponsor: Methodist Health System

Sex: All

Age: 18+

Code: NCT06336889

Recruiting

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

for
Refractory Solid Tumors, Relapsed Solid Tumors,
Location: Boston MA, Philadelphia PA, Houston TX,
Sponsor: Theodore Laetsch

Sex: All

Age: 1 - 30

Code: NCT06721689

Phase 1, Phase 2, Recruiting

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

for
B-cell Malignancy, Relapsed Cancer, Refractory Cancer,
Location: New York NY, Philadelphia PA, Rochester NY,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06634589

Phase 1, Phase 2, Recruiting

Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)

for
FSHD
Location: Baltimore MD, Ottawa, Richmond VA, Rochester NY,
Sponsor: University of Kansas Medical Center

Sex: All

Age: 0+

Code: NCT04635891

Recruiting

Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100

for
Ovarian Clear Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06065462

Phase 1, Phase 2, Recruiting

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

for
Pancreatic Carcinoma
Location: Boston MA, Baltimore MD, Pittsburgh PA, Atlanta GA,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06271291

Recruiting

Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

for
Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer,
Location: Boston MA, Philadelphia PA, Washington, D.C. DC,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 12+

Code: NCT05668962

Phase 2, Recruiting

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

for
Cervical Esophagus Adenocarcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04615013

Phase 1, Recruiting

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New York NY, New Brunswick NJ, Orlando FL,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT05932862

Phase 1, Recruiting

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

for
Colorectal Cancer, CRC, Pancreatic Ductal Adenocarcinoma, PDAC,
Location: Boston MA, New Haven CT, Lake Success NY, New York NY,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06445062

Phase 1, Phase 2, Recruiting

Ovulation Induction With Clomiphene Citrate and Dexamethasone

for
Infertility
Location: Ft. Sam Houston TX
Sponsor: San Antonio Military Medical Center

Sex: Female

Age: 18 - 40

Code: NCT01856062

Recruiting

A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

for
Advanced Melanoma
Location: Hartford CT, Commack NY, Uniondale NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06594991

Phase 2, Recruiting

Popular cities in Texas

With a broad healthcare network and leading medical research centers, Texas is a key location for a wide range of clinical trials. Major institutions such as MD Anderson Cancer Center, Baylor College of Medicine, UT Southwestern Medical Center, and Texas Heart Institute are at the forefront of these studies.

Why choose Texas for clinical trials?

Texas offers unique advantages for those participating in clinical trials. The state's diverse population provides a broad range of participants, which enhances the reliability and relevance of research findings. Texas is also known for its innovative research environment, with a strong focus on medical advancements and cutting-edge studies.

By choosing to participate in a clinical trial in Texas, you contribute to important medical research while benefiting from a well-established and supportive clinical research system.

Common conditions studied in Texas

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Texas